Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentric Double-blind Placebo-controlled Randomized Parallel-group Clinical Trial of Safety and Efficacy of New Dosage Schedule for Dietressa Drug in Treatment of Obese Patients

NCT01570829 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT01570829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01570829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentric Double-blind Placebo-controlled Randomized Parallel-group Clinical Trial of Safety and Efficacy of New Dosage Schedule for Dietressa Drug in Treatment of Obese Patients
Lead sponsor
Materia Medica Holding
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2011
Completion date
June 30, 2013
Enrollment
331 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

obesity